Rajiv Radhakrishnan
Rajiv Radhakrishnan
Yale University School of Medicine
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Gone to pot–a review of the association between cannabis and psychosis
R Radhakrishnan, ST Wilkinson, DC D’Souza
Frontiers in psychiatry 5, 54, 2014
Suicide: an Indian perspective
R Radhakrishnan, C Andrade
Indian journal of psychiatry 54 (4), 304-319, 2012
Marijuana Legalization: Impact on Physicians and Public Health
ST Wilkinson, S Yarnell, R Radhakrishnan, SA Ball, DC D'Souza
Annual Review of Medicine, 2015
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
G Hindley, K Beck, F Borgan, CE Ginestet, R McCutcheon, D Kleinloog, ...
The Lancet Psychiatry 7 (4), 344-353, 2020
Hormonal treatments for major depressive disorder: state of the art
JB Dwyer, A Aftab, R Radhakrishnan, A Widge, CI Rodriguez, ...
American Journal of Psychiatry 177 (8), 686-705, 2020
The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments
C Andrade, R Radhakrishnan
Indian journal of psychiatry 51 (1), 12-25, 2009
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled …
DC D'Souza, J Cortes-Briones, G Creatura, G Bluez, H Thurnauer, ...
The Lancet Psychiatry, 2018
Human Laboratory Studies on Cannabinoids and Psychosis
M Sherif, R Radhakrishnan, DC D'Souza, M Ranganathan
Biological Psychiatry, 2016
Impact of cannabis use on the development of psychotic disorders
ST Wilkinson, R Radhakrishnan, DC D’Souza
Current addiction reports 1, 115-128, 2014
Prayer and healing: A medical and scientific perspective on randomized controlled trials
C Andrade, R Radhakrishnan
Indian journal of psychiatry 51 (4), 247-253, 2009
Grey matter volume differences associated with extremely low levels of cannabis use in adolescence
C Orr, P Spechler, Z Cao, M Albaugh, B Chaarani, S Mackey, D D'Souza, ...
Journal of Neuroscience 39 (10), 1817-1827, 2019
Reduced brain cannabinoid receptor availability in schizophrenia
M Ranganathan, J Cortes-Briones, R Radhakrishnan, H Thurnauer, ...
Biological psychiatry 79 (12), 997-1005, 2016
Association of cannabis use during adolescence with neurodevelopment
MD Albaugh, J Ottino-Gonzalez, A Sidwell, C Lepage, A Juliano, ...
JAMA psychiatry 78 (9), 1031-1040, 2021
A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
ST Wilkinson, R Radhakrishnan, DC D'Souza
Journal of Clinical Psychiatry 77 (8), 1050-1064, 2016
Thyroid dysfunction in major psychiatric disorders in a hospital-based sample.
R Radhakrishnan, S Calvin, J Singh, B Thomas, K Srinivasan
Indian Journal of Medical Research 138, 888-893, 2013
The Link Between the Immune System, Environment, and Psychosis
R Radhakrishnan, M Kaser, S Guloksuz
Schizophrenia Bulletin, 2017
Acute effects of THC on time perception in frequent and infrequent cannabis users
RA Sewell, A Schnakenberg, J Elander, R Radhakrishnan, A Williams, ...
Psychopharmacology 226, 401-413, 2013
Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study
DC D'souza, R Radhakrishnan, E Perry, S Bhakta, NM Singh, R Yadav, ...
Neuropsychopharmacology 38 (3), 492-503, 2013
Evidence that environmental and familial risks for psychosis additively impact a multidimensional subthreshold psychosis syndrome
LK Pries, S Guloksuz, M Ten Have, R De Graaf, S Van Dorsselaer, ...
Schizophrenia Bulletin 44 (4), 710-719, 2018
Asian Indians in America: The influence of values and culture on mental health.
RM Chandra, L Arora, UM Mehta, A Asnaani, R Radhakrishnan
Asian J Psychiatry, S1876-2018(15)00222-1., 2015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20